Tubule-specific ablation of endogenous Β-catenin aggravates acute kidney injury in mice

Kidney International

Volumn 82, Issue 5, 2012, Pages 537-547

  Zhou, Dong ^a,b   Li, Yingjian ^a   Lin, Lin ^a   Zhou, Lili ^a,c   Igarashi, Peter ^d   Liu, Youhua ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

acute kidney injury; apoptosis; Wnt; catenin

Indexed keywords

BETA CATENIN; CREATININE; PROTEIN BAX; PROTEIN KINASE B; PROTEIN P53; SURVIVIN; UVOMORULIN; WNT1 PROTEIN;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE EXACERBATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; KNOCKOUT MOUSE; MOLECULAR PATHOLOGY; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RENAL PROTECTION; UPREGULATION;

EID: 84865261784     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2012.173     Document Type: Article

References (50)

1. Bonventre JV, Weinberg JM. Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol 2003; 14: 2199-2210. (Pubitemid 36909930)
2. Pabla N, Dong Z. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int 2008; 73: 994-1007. (Pubitemid 351543900)
3. Havasi A, Borkan SC. Apoptosis and acute kidney injury. Kidney Int 2011; 80: 29-40.
4. Angers S, Moon RT. Proximal events in Wnt signal transduction. Nat Rev Mol Cell Biol 2009; 10: 468-477.
5. MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 2009; 17: 9-26.
6. Liu Y. New insights into epithelial-mesenchymal transition in kidney fibrosis. J Am Soc Nephrol 2010; 21: 212-222.
7. Wang D, Dai C, Li Y et al. Canonical Wnt/b-catenin signaling mediates transforming growth factor-β1-driven podocyte injury and proteinuria. Kidney Int 2011; 80: 1159-1169.
8. Kang YS, Li Y, Dai C et al. Inhibition of integrin-linked kinase blocks podocyte epithelial-mesenchymal transition and ameliorates proteinuria. Kidney Int 2010; 78: 363-373.
9. Li Y, Tan X, Dai C et al. Inhibition of integrin-linked kinase attenuates renal interstitial fibrosis. J Am Soc Nephrol 2009; 20: 1907-1918.
10. Lade AG, Monga SP. Beta-catenin signaling in hepatic development and progenitors: which way does the WNT blow? Dev Dyn 2011; 240: 486-500.
11. Schmidt-Ott KM, Barasch J. WNT/beta-catenin signaling in nephron progenitors and their epithelial progeny. Kidney Int 2008; 74: 1004-1008.
12. Karner CM, Chirumamilla R, Aoki S et al. Wnt9b signaling regulates planar cell polarity and kidney tubule morphogenesis. Nat Genet 2009; 41: 793-799.
13. Dai C, Stolz DB, Kiss LP et al. Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria. J Am Soc Nephrol 2009; 20: 1997-2008.
14. He W, Dai C, Li Y et al. Wnt/beta-catenin signaling promotes renal interstitial fibrosis. J Am Soc Nephrol 2009; 20: 765-776.
15. von Toerne C, Schmidt C, Adams J et al. Wnt pathway regulation in chronic renal allograft damage. Am J Transplant 2009; 9: 2223-2239.
16. Surendran K, Schiavi S, Hruska KA. Wnt-dependent beta-catenin signaling is activated after unilateral ureteral obstruction, and recombinant secreted frizzled-related protein 4 alters the progression of renal fibrosis. J Am Soc Nephrol 2005; 16: 2373-2384. (Pubitemid 41725055)
17. Liu Y. Cellular and molecular mechanisms of renal fibrosis. Nat Rev Nephrol 2011; 7: 684-696.
18. Nelson PJ, von Toerne C, Grone HJ. Wnt-signaling pathways in progressive renal fibrosis. Expert Opin Ther Targets 2011; 15: 1073-1083.
19. He W, Kang YS, Dai C et al. Blockade of Wnt/b-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury in adriamycin nephropathy. J Am Soc Nephrol 2011; 22: 90-103.
20. Hao S, He W, Li Y et al. Targeted inhibition of b-catenin/CBP signaling ameliorates renal interstitial fibrosis. J AmSoc Nephrol 2011; 22: 1642-1653.
21. Liu Y, Tolbert EM, Lin L et al. Up-regulation of hepatocyte growth factor receptor: an amplification and targeting mechanism for hepatocyte growth factor action in acute renal failure. Kidney Int 1999; 55: 442-453. (Pubitemid 29082871)
22. Bengatta S, Arnould C, Letavernier E et al. MMP9 and SCF protect from apoptosis in acute kidney injury. J Am Soc Nephrol 2009; 20: 787-797.
23. Dai C, Yang J, Liu Y. Single injection of naked plasmid encoding hepatocyte growth factor prevents cell death and ameliorates acute renal failure in mice. J Am Soc Nephrol 2002; 13: 411-422. (Pubitemid 34106284)
24. Wei MC, Zong WX, Cheng EH et al. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 2001; 292: 727-730. (Pubitemid 32385543)
25. Ruiz-Vela A, Opferman JT, Cheng EH et al. Proapoptotic BAX and BAK control multiple initiator caspases. EMBO Rep 2005; 6: 379-385. (Pubitemid 40561632)
26. Kojima K, Shimanuki M, Shikami M et al. Cyclin-dependent kinase 1 inhibitor RO-3306 enhances p53-mediated Bax activation and mitochondrial apoptosis in AML. Cancer Sci 2009; 100: 1128-1136.
27. Gardai SJ, Hildeman DA, Frankel SK et al. Phosphorylation of Bax Ser184 by Akt regulates its activity and apoptosis in neutrophils. J Biol Chem 2004; 279: 21085-21095. (Pubitemid 38656511)
28. Altieri DC. Survivin and IAP proteins in cell-death mechanisms. Biochem J 2010; 430: 199-205.
29. Yamamoto H, Ngan CY, Monden M. Cancer cells survive with survivin. Cancer Sci 2008; 99: 1709-1714.
30. Zhang T, Otevrel T, Gao Z et al. Evidence that APC regulates surviving expression: a possible mechanism contributing to the stem cell origin of colon cancer. Cancer Res 2001; 61: 8664-8667. (Pubitemid 34013874)
31. Henderson Jr WR, Chi EY, Ye X et al. Inhibition of Wnt/b-catenin/CREB binding protein (CBP) signaling reverses pulmonary fibrosis. Proc Natl Acad Sci USA 2010; 107: 14309-14314.
32. He W, Tan R, Dai C et al. Plasminogen activator inhibitor-1 is a transcriptional target of the canonical pathway of Wnt/b-catenin signaling. J Biol Chem 2010; 285: 24665-24675.
33. Hu K, Lin L, Tan X et al. tPA protects renal interstitial fibroblasts and myofibroblasts from apoptosis. J Am Soc Nephrol 2008; 19: 503-514. (Pubitemid 351355394)
34. Alves da Costa C, Mattson MP, Ancolio K et al. The C-terminal fragment of presenilin 2 triggers p53-mediated staurosporine-induced apoptosis, a function independent of the presenilinase-derived N-terminal counterpart. J Biol Chem 2003; 278: 12064-12069. (Pubitemid 36800183)
35. Wang Z, Havasi A, Gall JM et al. Beta-catenin promotes survival of renal epithelial cells by inhibiting Bax. J Am Soc Nephrol 2009; 20: 1919-1928.
36. Linkermann A, Brasen JH, Himmerkus N et al. Rip1 (receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia/reperfusion injury. Kidney Int 2012; 81: 751-761; advance online publication doi: 10.1038/ki.2011.1450.
37. Shao X, Somlo S, Igarashi P. Epithelial-specific Cre/lox recombination in the developing kidney and genitourinary tract. J Am Soc Nephrol 2002; 13: 1837-1846. (Pubitemid 34700608)
38. Li L, Zepeda-Orozco D, Black R et al. Autophagy is a component of epithelial cell fate in obstructive uropathy. Am J Pathol 2010; 176: 1767-1778.
39. Igarashi P. Kidney-specific gene targeting. J Am Soc Nephrol 2004; 15: 2237-2239. (Pubitemid 39031363)
40. Galluzzi L, Morselli E, Kepp O et al. Targeting p53 to mitochondria for cancer therapy. Cell Cycle 2008; 7: 1949-1955. (Pubitemid 352030339)
41. Moll UM, Wolff S, Speidel D et al. Transcription-independent proapoptotic functions of p53. Curr Opin Cell Biol 2005; 17: 631-636.
42. Vasudevan KM, Garraway LA. AKT signaling in physiology and disease. Curr Top Microbiol Immunol 2010; 347: 105-133.
43. Kim PJ, Plescia J, Clevers H et al. Survivin and molecular pathogenesis of colorectal cancer. Lancet 2003; 362: 205-209. (Pubitemid 36859937)
44. Zhuang S, Schnellmann RG. Suramin promotes proliferation and scattering of renal epithelial cells. J Pharmacol Exp Ther 2005; 314: 383-390. (Pubitemid 41058276)
45. Heikkila E, Juhila J, Lassila M et al. b-Catenin mediates adriamycin-induced albuminuria and podocyte injury in the adult mouse kidneys. Nephrol Dial Transplant 2010; 25: 2437-2446.
46. Zhou J, Qu J, Yi XP et al. Upregulation of gamma-catenin compensates for the loss of beta-catenin in adult cardiomyocytes. Am J Physiol Heart Circ Physiol 2007; 292: H270-H276. (Pubitemid 46115923)
47. Wickline ED, Awuah PK, Behari J et al. Hepatocyte gamma-catenin compensates for conditionally deleted b-catenin at adherens junctions. J Hepatol 2011; 55: 1256-1262.
48. Li Y, Wen X, Liu Y. Tubular cell dedifferentiation and peritubular inflammation are coupled by the transcription regulator Id1 in renal fibrogenesis. Kidney Int 2012; 81: 880-891; advance online publication, doi:10.1038/ki.2011.469.
49. Dai C, Saleem MA, Holzman LB et al. Hepatocyte growth factor signaling ameliorates podocyte injury and proteinuria. Kidney Int 2010; 77: 962-973.
50. Dai C, Stolz DB, Bastacky SI et al. Essential role of integrin-linked kinase in podocyte biology: bridging the integrin and slit diaphragm signaling. J Am Soc Nephrol 2006; 17: 2164-2175 (Pubitemid 44141906)